Author Claim Review

Examine the evidence base and provenance of specific claims made by authors or groups.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review

Explore by Goal

Quick Explanation Copied

Frank M. Aarestrup is a world-leading genomic epidemiologist of antimicrobial resistance: 926 works, ~63,600 citations, h-index 113 (OpenAlex), and co-authorship of field-defining bioinformatics tools (ResFinder, PlasmidFinder, KMA, MLST-from-WGS) alongside rigorous surveillance and One Health AMR studies

Long Explanation

Scientific Strength of Frank M. Aarestrup

Frank M. Aarestrup (Technical University of Denmark) is among the most influential scientists in antimicrobial resistance (AMR) genomics. OpenAlex records 926 works, ~63,600 citations, and an h-index of 113, with citation rates accelerating after 2012 (peaking above 5,500 citations/year since 2021) — a trajectory reflecting his pivot to whole-genome sequencing surveillance. His 2012 ResFinder paper alone has ~4,982 citations
Feedback:

Updated: November 02, 2026

BGPT Author Review

Scientific Quality

100%

H-index 113, ~63.6k citations, 926 works; creator of field-standard tools (ResFinder, PlasmidFinder, KMA, CSI Phylogeny); decades of consistent, reproducible, methodologically diverse AMR genomics spanning surveillance, molecular mechanisms, and modeling. Rare combination of breadth, tool-building, and policy relevance.

Communication Quality

80%

Papers are well-structured with explicit methods, limitations, and falsification criteria; public code/data (GitHub, ENA, Microreact). Less emphasis on lay communication; dense technical output. Co-authored web tools improve accessibility of his methods.

Author Novelty

90%

Pioneered WGS-based resistance gene detection and real-time genomic surveillance; consistently early adopter and co-developer of disruptive methodology (ONT field metagenomics, metagenomic sewage monitoring, single-cell sequencing for resistome).

Scientific Rigor

90%

Explicit QC pipelines, validation against culture/WGS, acknowledged sampling biases, reproducibility via open code and data; minor deduction for simulation-derived policy claims dependent on model assumptions and some small field cohorts.

Top Data Sources Export MCP

1. bla TEM resistance genes in Salmonella Typhi are predominantly found in Asia and Africa, acquired by a limited number of lineages (notably 4.3.1 and descendants) and spread clonally, with distinct flanking region patterns linked to genotypes, ARGs, plasmids, and countries. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. Portable, offline metagenomic sequencing directly from fecal samples in Burundi revealed that syndromic cholera diagnoses mask diverse etiologies of diarrhoeal disease and enabled on-site detection of Vibrio cholerae and other pathogens with AMR signatures to inform frontline outbreak response. [2026]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. Metagenomics-based AMR surveillance in Danish pig production demonstrates that pooling 50–100 pig faecal samples per monthly test with adequate sequencing depth enables faster, more reliable detection and forecasting of resistance gene changes under budget constraints, outperforming small pools and phenotypic methods. [2023]

7QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

4. Ceftiofur treatment with ESBL E. coli inoculation reshapes the calf fecal microbiome, decreasing richness and altering beta-diversity, while beta-lactamase genes rise in Muribaculaceae and mph(N) rises in Clostridium, accompanied by reduced virulence factors and shifts in key taxa as revealed by parallel metagenomic and single-cell sequencing. [2026]

7QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

5. Development and validation of a Clade Ib–specific real-time PCR assay for monkeypox virus enabling rapid clade discrimination during the 2023–2024 mpox outbreaks, with 82/92 clinical samples identified as Clade Ib and confirmed by whole-genome sequencing. [2024]

8QualityResults Limitations Context Blindspots Methods Sample Conflict

↗ Paper Review ↗ Full Paper

Key Insight

Aarestrup's citation surge post-2012 tracks not a single paper but infrastructure: tools like ResFinder become the substrate of an entire field's methods, multiplying citation half-life well beyond typical 5–7 year decay.

Keep Exploring

How has Aarestrup's methodology adoption (ResFinder, KMA) reshaped global AMR surveillance workflows in low-resource settings?

What are the sensitivity limits of offline ONT metagenomics for enteric pathogen detection versus conventional culture-based diagnostics?

How robust are metagenomics-based AMR forecasting models to environmental and seasonal confounders in livestock systems?

Analysis Wizard

Aggregating citation histories and OpenAlex metrics to visualize Aarestrup's scientific output trajectory and citation impact across years and topics.

Hypothesis Graveyard

PFGE as gold standard for bacterial subtyping — displaced by WGS/SNP-based methods he co-developed (e.g., MLST-from-genome, CSI Phylogeny).

Culture-first outbreak response — his Burundi work demonstrates field metagenomics can match or exceed culture in speed without internet dependency.

Potential Experiments

Cross-validate simulated Danish pig pooling predictions against real prospective surveillance data over 12 months, testing whether 50–100-pool metagenomics matches modeled detection times.

Deploy paired offline metagenomics and culture in a randomized outbreak diagnostic trial to quantify false positive/negative rates across all enteric pathogens, not just V. cholerae.

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

Training data overweight highly-cited Western-authored genomics literature; may underweight non-English or non-indexed contributions and over-reward tool papers.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

My BGPT

Trending